1. Home
  2. FNWB vs RVPH Comparison

FNWB vs RVPH Comparison

Compare FNWB & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWB
  • RVPH
  • Stock Information
  • Founded
  • FNWB 1923
  • RVPH 2006
  • Country
  • FNWB United States
  • RVPH United States
  • Employees
  • FNWB N/A
  • RVPH N/A
  • Industry
  • FNWB Banks
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNWB Finance
  • RVPH Health Care
  • Exchange
  • FNWB Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • FNWB 89.9M
  • RVPH 88.0M
  • IPO Year
  • FNWB 2015
  • RVPH N/A
  • Fundamental
  • Price
  • FNWB $10.86
  • RVPH $2.09
  • Analyst Decision
  • FNWB Hold
  • RVPH Strong Buy
  • Analyst Count
  • FNWB 1
  • RVPH 5
  • Target Price
  • FNWB $12.00
  • RVPH $11.40
  • AVG Volume (30 Days)
  • FNWB 16.2K
  • RVPH 1.8M
  • Earning Date
  • FNWB 01-29-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • FNWB 2.59%
  • RVPH N/A
  • EPS Growth
  • FNWB N/A
  • RVPH N/A
  • EPS
  • FNWB N/A
  • RVPH N/A
  • Revenue
  • FNWB $50,900,000.00
  • RVPH N/A
  • Revenue This Year
  • FNWB N/A
  • RVPH N/A
  • Revenue Next Year
  • FNWB $11.60
  • RVPH N/A
  • P/E Ratio
  • FNWB N/A
  • RVPH N/A
  • Revenue Growth
  • FNWB N/A
  • RVPH N/A
  • 52 Week Low
  • FNWB $8.91
  • RVPH $0.60
  • 52 Week High
  • FNWB $16.00
  • RVPH $4.83
  • Technical
  • Relative Strength Index (RSI)
  • FNWB 60.31
  • RVPH 60.41
  • Support Level
  • FNWB $10.80
  • RVPH $1.78
  • Resistance Level
  • FNWB $11.10
  • RVPH $2.15
  • Average True Range (ATR)
  • FNWB 0.22
  • RVPH 0.15
  • MACD
  • FNWB 0.03
  • RVPH 0.02
  • Stochastic Oscillator
  • FNWB 75.00
  • RVPH 88.30

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: